Oncternal Therapeutics Statistics

Total Valuation

ONCT has a market cap or net worth of $3.37 million. The enterprise value is -$11.01 million.

Market Cap	3.37M
Enterprise Value	-11.01M

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

ONCT has 2.96 million shares outstanding. The number of shares has increased by 1.60% in one year.

Current Share Class	2.96M
Shares Outstanding	2.96M
Shares Change (YoY)	+1.60%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.42%
Owned by Institutions (%)	13.33%
Float	2.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.56
Forward PS	4.49
PB Ratio	0.37
P/TBV Ratio	0.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.02.

Current Ratio	2.39
Quick Ratio	2.31
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -149.86% and return on invested capital (ROIC) is -93.35%.

Return on Equity (ROE)	-149.86%
Return on Assets (ROA)	-74.11%
Return on Capital (ROIC)	-93.35%
Revenue Per Employee	$72,033
Profits Per Employee	-$1.15M
Employee Count	30
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.17% in the last 52 weeks. The beta is 1.33, so ONCT's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-84.17%
50-Day Moving Average	1.37
200-Day Moving Average	6.04
Relative Strength Index (RSI)	39.44
Average Volume (20 Days)	89,859

Short Selling Information

The latest short interest is 45,352, so 1.53% of the outstanding shares have been sold short.

Short Interest	45,352
Short Previous Month	16,932
Short % of Shares Out	1.53%
Short % of Float	1.68%
Short Ratio (days to cover)	0.36

Income Statement

In the last 12 months, ONCT had revenue of $2.16 million and -$34.58 million in losses. Loss per share was -$11.69.

Revenue	2.16M
Gross Profit	-22.93M
Operating Income	-34.86M
Pretax Income	-35.97M
Net Income	-34.58M
EBITDA	n/a
EBIT	-34.86M
Loss Per Share	-$11.69

Full Income Statement

Balance Sheet

The company has $14.58 million in cash and $191,000 in debt, giving a net cash position of $14.39 million or $4.86 per share.

Cash & Cash Equivalents	14.58M
Total Debt	191,000
Net Cash	14.39M
Net Cash Per Share	$4.86
Equity (Book Value)	9.15M
Book Value Per Share	3.09
Working Capital	8.99M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-26.63M
Capital Expenditures	n/a
Free Cash Flow	-26.63M
FCF Per Share	-$9.00

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,613.10%
Pretax Margin	-1,599.95%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,364.68%

Dividends & Yields

ONCT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.60%
Shareholder Yield	-1.60%
Earnings Yield	-1,024.75%
FCF Yield	-789.33%

Analyst Forecast

The average price target for ONCT is $10.00, which is 777.19% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	777.19%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 8, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 8, 2024
Split Type	Reverse
Split Ratio	0.05:1

Scores

ONCT has an Altman Z-Score of -24.56 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-24.56
Piotroski F-Score	3